PITPNM2

PITPNM2 (Nir3) is a membrane-associated phosphatidylinositol transfer protein that operates at ER–plasma membrane contact sites to sustain phosphoinositide homeostasis during receptor-mediated signaling. It localizes to ER-PM junctions through its FFAT motif interaction with VAP proteins, where it transfers phosphatidylinositol from the ER to the PM to replenish PI(4,5)P2 consumed during PLC-coupled signaling downstream of TCR, GPCR, and phagocytic receptors; it binds phosphatidic acid generated at the PM as a signal to initiate lipid transfer, and works in tandem with Nir2 to achieve graded PIP2 replenishment (PMID:25887399, PMID:36581712, PMID:37376972). PITPNM2 is tyrosine-phosphorylated by PYK2 in a calcium-dependent manner and interacts with PYK2 via its C-terminal domain, while its VAP-B interaction remodels ER structure (PMID:10022914, PMID:15545272). Loss of Nir3 in mice impairs thymocyte development at TCRβ selection and positive selection owing to attenuated calcium mobilization, compromises phagocytic cup closure through reduced actin dynamics, and disrupts dim-light retinal circuitry by eliminating a rod-to-amacrine-to-ipRGC signaling pathway required for circadian photoentrainment (PMID:36581712, PMID:37376972, PMID:26269578).

1. 1999 High

   The identification of Nir3 as a PYK2-binding, calcium-sensing phosphatidylinositol transfer protein established the founding biochemical activities of the gene product — PI transfer, calcium binding, and regulation by tyrosine phosphorylation.

   Evidence Molecular cloning, co-immunoprecipitation from cell lysates and brain, in vivo PI transfer assay, and tyrosine phosphorylation assays

   PMID:10022914

   Open questions at the time

   • Lipid substrate specificity and directionality of transfer not defined
   • Structural basis of PYK2 interaction unknown
   • Physiological contexts requiring PYK2-Nir3 signaling axis not established
2. 1999 Medium

   Expression of mammalian PITPNM2 in Drosophila rdgB null flies suppressed retinal degeneration but did not fully restore electrophysiology, revealing conserved but incomplete functional overlap with RdgB1 and establishing membrane association through protein-protein interactions rather than transmembrane insertion.

   Evidence Subcellular fractionation, transgenic rescue in Drosophila rdgB2 null mutants, electroretinography

   PMID:10460238

   Open questions at the time

   • Identity of the protein partners mediating membrane association was unknown
   • Functional differences between Nir3 and Nir2/RdgB1 not mechanistically explained
3. 2001 High

   Knockout of PITPNM2 in mice revealed that the protein is dispensable for photoreceptor survival and standard phototransduction, redirecting the search for its physiological role away from classical photoreceptor function.

   Evidence Gene-targeted knockout mice with electroretinography, immunocytochemistry, and light microscopy up to 18 months

   PMID:11744244

   Open questions at the time

   • Non-photoreceptor retinal roles not examined
   • Potential redundancy with Nir2 not tested
4. 2004 High

   Discovery of the FFAT motif–mediated interaction between Nir3 and the ER-resident protein VAP-B provided the molecular basis for Nir3 targeting to ER-PM contact sites and revealed that this interaction induces dramatic ER remodeling and microtubule bundling.

   Evidence Co-expression, fluorescence microscopy, FFAT motif mutagenesis, interaction domain mapping

   PMID:15545272

   Open questions at the time

   • Whether ER remodeling is physiologically relevant or an overexpression artifact was unclear
   • Lipid transfer function was not linked to VAP-dependent localization
5. 2015 High

   Two parallel advances defined Nir3's distinct physiological roles: at ER-PM junctions, Nir3 was shown to maintain basal PIP2 homeostasis through phosphatidic acid–gated PI transfer working in tandem with Nir2; in the retina, Nir3 was localized to GABAergic amacrine cells where it is required for a dim-light circuit from rods to ipRGCs controlling circadian photoentrainment and pupillary responses.

   Evidence Live-cell PIP2 biosensors, PA binding assays, siRNA knockdown (lipid transfer); RdgB2−/− mice with behavioral assays, ipRGC electrophysiology, immunolocalization (retina)

   PMID:25887399 PMID:26269578

   Open questions at the time

   • Molecular basis of differential PA sensitivity between Nir2 and Nir3 unknown
   • Downstream targets in amacrine cells not identified
   • Whether Nir3 lipid transfer is the mechanism in the retinal circuit was not directly tested
6. 2019 Medium

   Proteomic and imaging studies showed Nir3 associates with Kv2.1/VAP complexes at neuronal ER-PM junctions, linking Nir-mediated PIP2 replenishment to voltage-gated potassium channel signaling domains.

   Evidence Mass spectrometry, co-immunoprecipitation, FRAP, PIP2 biosensors in Kv2.1-expressing neurons

   PMID:31594866

   Open questions at the time

   • Nir3 identified mainly by proteomics; direct functional contribution of Nir3 versus Nir2 at Kv2.1 junctions not resolved
   • Physiological consequence of Nir3 loss on neuronal excitability not tested
7. 2022 High

   Nir3 knockout in mice demonstrated that PIP2 replenishment after TCR stimulation depends on Nir3; loss of Nir3 attenuated calcium signaling in double-positive thymocytes and impaired T cell development at TCRβ selection and positive selection, establishing Nir3 as a non-redundant regulator of adaptive immune cell maturation.

   Evidence Pitpnm2−/− mice, PIP2 biosensors, calcium imaging, thymocyte flow cytometry, T cell functional assays

   PMID:36581712

   Open questions at the time

   • Whether Nir2 partially compensates at strong TCR signals not quantified
   • Mechanism by which Nir3 is selectively required at weak-signal thresholds not structurally explained
8. 2023 High

   CRISPR knockout of Nir2/Nir3 and rescue re-expression demonstrated that Nir3 sustains PI(4,5)P2 at phagocytic cups, supports store-operated calcium entry and actin ring assembly, and is rate-limiting for phagocytic cup closure, directly linking lipid transfer to an innate immune effector function.

   Evidence CRISPR-Cas9 double KO in macrophages, PIP2 biosensors, phagocytosis assays, actin imaging, calcium imaging, Nir3 re-expression rescue

   PMID:37376972

   Open questions at the time

   • Individual contributions of Nir2 versus Nir3 to phagocytosis not fully separated in the double KO
   • Structural basis of Nir3 recruitment to phagocytic cup ER cisternae unknown

• Key unresolved questions include the atomic structure of the Nir3 PITP domain and how it achieves distinct PA sensitivity from Nir2, whether Nir3 operates non-redundantly in additional signaling contexts (e.g., neuronal excitability via Kv2.1), and the in vivo significance of PYK2-mediated tyrosine phosphorylation for Nir3 lipid transfer activity.
• No crystal or cryo-EM structure of Nir3 PITP domain
• PYK2 phosphorylation sites and functional consequences not mapped in vivo
• Neuronal-specific knockout phenotypes beyond retina not characterized